Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for "Analgesics and anesthetics for systemic use.". The date of publication of the call for tenders is planned for January 2024.

The scope of procurement is described in more detail in Annex 1. The procurement will be divided in five (5) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots.

LOT 1: Fentanyl citrate 50 mcg/ml (10 ml per vial/ampoule, i.v. ATC N01AH01)

LOT 2: Haloperidol 5 mg/ml (1 ml per vial/ampoule, i.m. ATC N05AD01)

LOT 3: Midazolam hydrochlorid 5 mg/ml (10 ml per vial/ampoule, i.v. ATC N05CD08)

LOT 4: Glycopyrrhonium/neostigmin 0,5/2,5 mg/ml (1 ml per vial/ampoule i.v. ATC N07AA51)

LOT 5: Oxycodon hydrochlorid 20 mg (prolonged-release capsule/tablet, ATC N02AA05)

The minimum requirements for the products is described in Annex 1.1.

The contract will be awarded to one supplier for each lot based on a comparison of tenders.

Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option.

THL reserves the right to change the scope of the procurement and the minimum requirements in the published call for tenders.